Translations:Discovery and development of angiotensin receptor blockers/6/en: Difference between revisions
Jump to navigation
Jump to search
Importing a new version from external source |
(No difference)
|
Latest revision as of 10:25, 28 March 2024
Before that attempts had been made to develop useful Ang II receptor antagonists and initially, the main focus was on angiotensin peptide analogues. Saralasin and other Ang II analogues were potent Ang II receptor blockers but the main problem was a lack of oral bioavailability.